{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-128.5",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 128.5 - Cannabis Product Labeling Minimum Standards",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 128.5 - Cannabis Product Labeling Minimum Standards\n\nState Regulations\n(a) The principal packaging display panel\nshall contain the following information: (1)\nin milligrams per single serving of total THC (THC +[THCA x 0.877]), total CBD\n(CBD + [CBDA x 0.877]) content, and any other marketed\nphytocannabinoids; (2)\nif terpenes\nare marketed, a terpene profile; (3)\nin\nbold, milligrams per\npackage of total THC (THC + [THCA x 0.877]) and total CBD (CBD + [CBDA x\n0.877]) content; (4)\nthe amount of\ntotal THC (THC + [THCA x 0.877]) and any other marketed phytocannabinoids as a\npercentage of volume, except if the cannabis product is in the form of an\nedible; (5)\nnumber of servings per\npackage and, if applicable, the recommended size of a serving, except for\ncannabis flower and other forms of cannabis for vaporization; and\n(6)\nweight of cannabis product. (b) The retail package or, if it\nis used, the marketing layer shall contain the following information: (1)\na list of all ingredients in descending\norder of predominance by weight in the cannabis product - both active and\ninactive. The ingredient list shall include and separately list, in\nbold, any major allergens set forth in the Food Allergen Labeling\nand Consumer Protection Act of 2004, Title 21, as it relates to Food and Drugs, of the U.S. Code section 343, for misbranded food; (i) Edibles shall include a nutritional label\npursuant to Title 21, as it relates Food and Drugs, of the Codes of Federal\n\nRegulations section 101.9(c) for nutrition labeling of food, as amended from\ntime to time; and\n(ii)\n\nCannabis\nproducts marketed as dietary supplements shall include a supplement fact panel\npursuant to Title 21, as it relates to Food and Drugs, of the Codes of Federal\n\nRegulations section 101.36 for nutrition labeling of dietary supplements, as\namended from time to time; (2)\na list of any solvent used to produce the\ncannabis product, if applicable; (3)\ndate of expiration of the unopened\ncannabis product; (4)\nuse by\ndate; (5)\nproper storage\nconditions; (6)\nname, location (at\na minimum, city or zip code) license number, and direct contact information of\nthe processor; (7)\nany one of the\nfollowing three universal symbols at a minimum size of 1.25 inch in height for\nthe square symbol, 0.5 inch in width for the vertical symbol, and 0.5 inch in\nheight for the horizontal symbol. The symbol and its colors cannot be altered\nunless authorized by the Board and it shall be made conspicuous by printing the\nsymbol on, or outlining the symbol with, a contrasting color; Click to View\n\nImage\n(8)\nclear usage\ninstructions; (9)\nlot unique\nidentifier or lot number or bar code; (10)\na scannable bar code or QR code linked\nto a downloadable certificate of analysis or linked to a website where the\ncertificate of analysis can be downloaded; and\n(11)\nany other information required by the\n\nBoard. (c) Required\nlabeling shall be no smaller than 6-point font size. Labeling text shall be\nclearly written or printed and in the English language. In addition to the\nrequired labeling in English, licensees may include accurate foreign language\ntranslation(s) of the labeling text, provided such translation otherwise\ncomplies with this Part. (d) The\nmarketing layer is optional, but if used by a licensee in addition to the\nrequired packaging, it shall be labeled according to the requirements in\n\nSection\n128.6\nof this Part. (e) The information required pursuant to\n\nSection\n128.5\n(a) of this\n\nPart shall be unobstructed and conspicuous. A licensee may include the\ninformation required pursuant to Section\n128.5\n(a) of this\n\nPart by printing it directly onto the retail package or by affixing multiple\nlabels with the information to the retail package, provided that none of the\ninformation is obstructed. (f) The\nretail packaging or, if it is used, the marketing layer shall contain the\nfollowing warnings, provided however, if the word \"warning\" is clearly\nassociated with all warnings as a header then the word \"warning\" does not need\nto be included in the individual warnings where specifically indicated below: (1)\n\"This product contains cannabis and\nTHC\"; (2)\n\"KEEP OUT OF REACH OF\nCHILDREN AND PETS. For use only by persons 21 years and older\"; (3)\n\" Warning: Do not use if pregnant or\nnursing\"; (4)\n\"Poison Center\n1-800-222-1222\"; (5)\n\nFor cannabis\nproducts intended to be smoked, inhaled, or vaporized: \"Warning: Smoking or\nvaping is hazardous to health\"; (6)\n\nFor cannabis products intended to be ingested orally: \"Warning: Effects of this\nproduct may be delayed by 4 or more hours\"; (7)\n\nFor topical products: \"Warning: For\ntopical use only. Do not eat or smoke\"; and\n(8)\n\nAny other warning required by the\n\nBoard. (g) The warnings\nrequired pursuant to Section\n128.5\n(f) of this\n\nPart shall be displayed: (1)\nin the English\nlanguage; (2)\nin Times New Roman, Calibri, Arial, or Helvetica; (3)\nin text no smaller than size six (6) font; and\n(4)\nbolded. (h) In addition to the required warnings in\n\nSection\n128.5\n(f) of this\n\nPart, the retail packaging or marketing layer shall include any rotating health\nwarnings as determined by the Office. (i) To allow for labeling on small packaging, the information required pursuant to sections\n128.5\n(b), (f), and\n(h) of this Part may appear on labels that are, not by means of limitation: accordion, booklet, dry release, expandable, extendable, or peel-and-reseal. This allowance does not apply to: (1)\n\nThe\nprincipal packaging display panel minimum standards specified in section\n128.5\n(a) of this\n\nPart; (2)\nthe universal symbol\nspecified in Section\n128.5\n(b)(7)\nof\nthis Part; and\n(3)\nthe following\ntwo required warnings: (i) \"This product\ncontains cannabis and THC\"; and\n(ii)\n\nIn all capital letters as indicated: \"KEEP OUT OF REACH OF CHILDREN AND PETS. For use only by persons 21 years and\nolder\". (j) Any research licensee conducting research approved by the Office involving\nhuman subjects shall comply with all packaging and labeling requirements, unless the licensee receives prior written approval for a waiver of specific\npackaging or labeling requirements in connection with any research approved by\nthe Office. The waiver may extend to a licensee providing cannabis products for\nan approved research study. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 9\nยง\n128.5\n\nAdopted\n\nNew\n\nYork State Register March 22, 2023/Volume XLV, Issue 12, eff. 3/22/2023\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 32084
}